Experience. Commitment. Results.
CureVac N.V. (NASDAQ: CVAC) related to its sale to BioNTech SE. Under the terms of the proposed transaction, each CureVac share will be exchanged for approximately $5.46 in BioNTech ADSs. Upon closing of the proposed transaction, CureVac shareholders are expected to own between 4% and 6% of BioNTech.
Cantaloupe, Inc. (NASDAQ: CTLP) related to its sale to 365 Retail Markets, LLC for $11.20 per share in cash.
BGSF, Inc.’s (NYSE: BGSF) related to the sale of its Professional Division to INSPYR Solutions for $99 million.
M2i Global, Inc. (OTCQB: MTWO) related to its merger with Volato Group, Inc. Upon completion of the proposed merger, M2i will own approximately 90% of the combined company.
Elevation Oncology, Inc. (NASDAQ: ELEV) related to its sale to Concentra Biosciences, LLC. Under the terms of the proposed transaction, Elevation shareholders will receive $0.36 in cash per share, plus one non-tradeable contingent value right representing the right to receive: (i) 100% of the closing net cash in excess of $26.4 million; and (ii) 80% … Read more
Crown Electrokinetics Corp. (OTCMKTS: CRKN) related to its sale to Crown EK Acquisition LLC for $3.15 per share.
Blueprint Medicines Corporation (NASDAQ: BPMC) related to it sale to Sanofi. Under the terms of the proposed transaction, Sanofi will pay $129.00 per share in cash at closing, and Blueprint shareholders also will receive one non-tradeable contingent value right (CVR) entitling the holder to receive two potential milestone payments of $2.00 and $4.00 per CVR … Read more
Atai Life Sciences N.V. (NASDAQ: ATAI) related to the acquisition of Beckley Psytech Limited.
Heliogen, Inc. (OTCQX: HLGN) related to its sale to Zeo Energy Corp.. Upon closing of the proposed transaction, Heliogen’s securityholders will receive shares of Zeo’s Class A common stock valued at approximately $10 million in the aggregate, based on a Zeo Class A common stock price of $1.5859 per share, and subject to an adjustment … Read more
Know Labs, Inc. (NYSE: KNW) related to its sale to Goldeneye 1995 LLC. Under the terms of the agreement, the Buyer will acquire that number of shares of the Company’s common stock obtained by dividing (i) the sum of 1,000 Bitcoin and a cash sum to retire existing debt, redeem outstanding preferred equity and provide … Read more